Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

European Commission Approves Ipsen’s Cabometyx® for Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib

americanpharmaceuticalreviewNovember 19, 2018

Tag: Hepatocellular , European , Cabometyx

PharmaSources Customer Service